These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 3201864

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitory effect of simultaneous intraportal administration of 5-fluorouracil, uracil and degradable starch microspheres on experimental hepatic micrometastasis, is of colon cancer.
    Nakasaki H, Hanaue H, Yasuda S, Fujii K, Tajima T, Mitomi T, Kurosawa T.
    Tokai J Exp Clin Med; 1994 Sep; 19(1-2):83-91. PubMed ID: 7660389
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Concentrations of 5-fluorouracil (5-FU) in serum and tissues at venous injection of tegafur or 5-FU--clinical study on colorectal cancer].
    Kojima T, Suzumura K, Kanemitsu T, Miyashita A, Inamura Y, Owa Y, Naruse T.
    Gan To Kagaku Ryoho; 1998 Mar; 25(4):547-51. PubMed ID: 9530361
    [Abstract] [Full Text] [Related]

  • 5. Degradable starch microspheres in cytostatic treatment of a liver carcinoma; experimental studies in rats with 5-fluorouracil, tauromustine, carmustine, doxorubicin and RSU-1069.
    Roos G, Christensson PI, el Hag IA, Jakobsson B, Teder H, Stenram U.
    Anticancer Res; 1993 Mar; 13(3):635-41. PubMed ID: 8317891
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A case report of intra-hepatic arterial infusion of mitomycin C with degradable starch microspheres for liver metastases of sigmoid colon carcinoma].
    Ochiai T, Maruyama M, Ebuchi M, Nagahama T, Takashima I, Hasegawa K, Natsui S, Sakoma T.
    Gan To Kagaku Ryoho; 2002 Nov; 29(12):2080-3. PubMed ID: 12484007
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [5-Fluorouracil concentration in various tissues from cancer patients after oral administration of 5-fluorouracil].
    Nakamura T, Hashimoto I, Sawada Y, Mikami J, Yoshimoto M, Nishidai H, Nakanishi Y, Kashi Y.
    Gan To Kagaku Ryoho; 1984 May; 11(5):1037-48. PubMed ID: 6721512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheres.
    Teder H, Erichsen C, Christensson PI, Jönsson PE, Stenram U.
    Cancer Drug Deliv; 1987 May; 4(3):169-76. PubMed ID: 2453264
    [Abstract] [Full Text] [Related]

  • 15. [Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome].
    Li Y, Liu BW, DU WL, Song ZC, Zhao Q, Fan LQ, Yang JQ, Li QJ, Wang MX, Jiao ZK, Zhang ZD.
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):638-40. PubMed ID: 15634532
    [Abstract] [Full Text] [Related]

  • 16. [Comparison of targeting distribution of two kinds of fluorouracil magnetic albumin microspheres in colorectal neoplasm nude mice in vivo under magnetic field].
    Liu ZC, Liu JG, Kong X, Jiang T, Gu J.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Jun; 15(6):622-4. PubMed ID: 22736137
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Temporary blood flow stasis with degradable starch microspheres (DSM) for liver metastases in a rat model.
    Flowerdew AD, Richards HK, Taylor I.
    Gut; 1987 Oct; 28(10):1201-7. PubMed ID: 3678948
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical modulation of intraperitoneal fluorouracil by allopurinol-the effect on an experimental adenocarcinoma in the liver.
    Lindnér P, Carlsson G, Gustavsson B, Holmberg SB, Naredi P, Peterson A, Hafström L.
    Anticancer Res; 1994 Oct; 14(3A):847-52. PubMed ID: 8074485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.